GovChime
Notice ID: 3bf738822b4c4d1196eb3fc221e01ff5Combined Synopsis/Solicitation

Acquisition of Filovirus Point-of-Care (PoC) Diagnostic Tests

Archived on June 8, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:59 PM UTC−04:00
Posted
May 23, 2022
Notice type
Combined Synopsis/Solicitation
Agency
Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Notice details

Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Place of performance
Bethlehem, PA, 18015
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75A50122Q00017
Notice ID
3bf738822b4c4d1196eb3fc221e01ff5

Description

The Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS) seeks to purchase diagnostic tests for Ebola virus. The test must be a point of care, handheld, lateral flow, rapid antigen test for Ebola virus that is either emergency use authorized or 510(k) cleared by the U.S. Food and Drug Administration. The test sample type must be oral fluid from cadavers. The test must be for use on individuals suspected to have recently died from the Ebola virus disease. OraSure Technologies is uniquely qualified because their product is the only test that meets all the following salient characteristics: For point of care use Handheld Lateral flow, rapid antigen test for Ebola virus Either emergency use authorized, or Section 510(k) cleared by the U.S. Food and Drug Administration (FDA) Samples oral fluid from cadavers For use on individuals or suspected to have recently died from the Ebola virus disease Nine (9) month shelf life from date of delivery Alternative tests will not work because the Government will be unable to assess infection with the Ebola Virus in individuals and cadavers. The inability to assess infections would jeopardize HHS public health mission in a way that would result in unacceptable risks to the health of the public.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75A50122Q00017
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentMay 19, 2022

    Acquisition of Filovirus Point-of-Care (PoC) Diagnostic Tests

    Notice 3bf738822b4c4d1196eb3fc221e01ff5 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75A50122Q00017

Archive Date

Jun 8, 2022

Office Address

WASHINGTON, DC, 20515